Metastatic gastric cancer – Life with Disease

Go back

Metastatic gastric cancer represents an advanced stage of stomach cancer where the disease has spread beyond the stomach to other parts of the body, making it one of the most challenging forms of cancer to manage and requiring comprehensive support for patients and their families.

Understanding the Outlook: What to Expect with Metastatic Gastric Cancer

When someone is told they have metastatic gastric cancer, it means the cancer that started in their stomach has traveled to distant parts of the body. This is also called stage 4 stomach cancer, and understanding what this means for survival and quality of life is important, though often deeply emotional.[2]

The outlook for metastatic gastric cancer is serious. Research shows that the median survival time for people with this advanced stage is approximately three months overall, though this varies depending on where the cancer has spread and what treatments are received.[3] When the cancer spreads to the bones or liver, survival times tend to be even shorter, around two months.[3] These statistics represent averages across many patients, and individual experiences can differ based on many factors including age, overall health, and how the cancer responds to treatment.

Studies examining different treatment approaches have shown that patients who receive chemotherapy alone typically survive about seven months, while those who receive both surgery and chemotherapy can see their survival extend to approximately 14 months.[6][14] Without any treatment, survival is typically only three to five months.[14] These numbers reflect the reality that while metastatic gastric cancer cannot usually be cured, treatments can help control the disease and extend life.[2][5]

Age plays a role in prognosis as well. Stomach cancer more commonly affects older adults, with the average age at diagnosis being 68 years, and about 60 percent of cases occurring in people over 65.[1] Younger patients may have different outcomes and may be able to tolerate more aggressive treatments.

⚠️ Important
Survival statistics represent averages and cannot predict any individual person’s outcome. Many factors influence how long someone lives with metastatic gastric cancer, including the specific characteristics of their cancer, their overall health, and how they respond to treatment. Every person’s journey is unique, and talking openly with your doctor about your specific situation is essential.

It’s completely normal to feel overwhelmed, uncertain, and anxious when hearing this diagnosis. Many people find they cannot think about anything else at first.[2] Some people want to know every detail about their prognosis right away, while others prefer to take in information gradually. There is no right or wrong way to feel, and you can always ask for more information when you’re ready.[2]

How the Disease Progresses Without Treatment

Understanding how metastatic gastric cancer develops and spreads helps explain why early detection and treatment are so important. Stomach cancer typically develops slowly over many years, with small changes occurring in the DNA (the genetic instructions) of stomach cells.[1] These changes tell the cells to multiply too rapidly and to keep living when they should die. As these abnormal cells accumulate, they form tumors.

Once cancer has spread beyond the stomach, it is considered metastatic. The most common places where gastric cancer spreads are the liver, which is affected in about 48 percent of patients with metastatic disease, and the peritoneum (the tissue lining the abdominal cavity), which is involved in about 32 percent of cases.[3] The lungs are affected in approximately 15 percent of patients, and bones in about 12 percent.[3]

The pattern of spread can vary depending on where in the stomach the cancer started. Cancer beginning in the cardia (the upper part of the stomach near where it connects to the esophagus) tends to spread differently than cancer starting in other parts of the stomach. Cardia cancers more frequently spread to the lungs, nervous system, and bones, while cancers from other parts of the stomach more often spread within the peritoneum.[3]

The type of cancer cells also influences where the cancer spreads. For example, signet ring adenocarcinomas (a specific type of stomach cancer cell) more frequently spread to the peritoneum, bones, and ovaries, but less often to the lungs and liver compared to typical adenocarcinomas.[3]

Without treatment, the cancer continues to grow both at the original site in the stomach and at the distant locations where it has spread. This progression leads to worsening symptoms and complications that increasingly interfere with normal bodily functions. The body’s ability to digest food becomes impaired, leading to severe weight loss and malnutrition. The cancer can cause blockages in the stomach or intestines, preventing food from passing through. Bleeding from the tumor can lead to severe anemia. As the disease advances, pain typically increases and overall functioning declines.

Potential Complications and Challenges

Metastatic gastric cancer can lead to numerous complications that significantly impact a patient’s wellbeing and require careful management. These complications can arise from the cancer itself, from where it has spread, or sometimes from the treatments used to control it.

One of the most distressing complications is a blockage in the stomach or intestines. The cancer might block the entrance to the stomach or the opening to the small bowel, preventing food from passing through.[17] When this happens, patients experience severe pain, persistent vomiting, and feel very unwell. This is a medical emergency requiring hospital care. Doctors may place a stent (a hollow tube) into the stomach to allow food to pass, use laser therapy to burn away cancer cells causing the blockage, or in some cases recommend surgery.[17][15]

Bleeding is another serious complication. The tumor in the stomach can bleed, causing patients to vomit blood or pass very dark, tar-like stools. This bleeding can be gradual, leading to anemia that causes extreme fatigue and weakness, or it can be sudden and severe, requiring emergency treatment.

Severe weight loss and malnutrition are nearly universal complications. Many patients lose their appetite completely and find it difficult or impossible to eat adequate amounts of food.[17] The cancer itself increases the body’s nutritional needs while simultaneously making it harder to eat and digest food. This creates a dangerous cycle where patients become increasingly weak and malnourished, which in turn makes them less able to tolerate treatments. Malnutrition can progress rapidly in gastric cancer patients and has a significant impact on both quality of life and ability to continue treatment.[21]

Persistent nausea and vomiting are common and can have various causes. Sometimes it’s the cancer itself causing these symptoms, other times it’s related to treatments like chemotherapy, pain medications, or constipation.[17] Controlling nausea often requires trying different medications or combinations of medications to find what works best for each individual patient.

Pain is a significant concern, though not everyone with metastatic gastric cancer experiences it. The pain can come from the tumor itself, from where the cancer has spread, or from complications like blockages.[17] When cancer spreads to bones, it can cause severe bone pain and increase the risk of fractures. Cancer in the liver can cause abdominal pain and jaundice, which is a yellowing of the skin and eyes caused by liver dysfunction.[4]

When cancer spreads to the lungs, patients may develop shortness of breath, chronic cough, or chest pain. Spread to the bladder or bowels can cause blood in the urine, painful urination, difficulty with bowel movements, or blood in the stool.[4] Ascites, which is a buildup of fluid in the abdomen, can occur when cancer spreads to the peritoneum, causing the belly to become swollen and uncomfortable.[4]

Difficulty swallowing can develop if the tumor is near the junction between the esophagus and stomach, making it progressively harder to eat solid foods and eventually even liquids. This complication often requires intervention such as a stent or feeding tube to ensure adequate nutrition.

Impact on Daily Life and Coping Strategies

Living with metastatic gastric cancer affects nearly every aspect of daily life, from the most basic physical activities to emotional wellbeing, relationships, work, and future planning. Understanding these impacts and learning strategies to cope with them is crucial for maintaining the best possible quality of life.

Physical limitations often become profound as the disease progresses. The extreme fatigue that accompanies advanced cancer is unlike normal tiredness—it is overwhelming and doesn’t improve with rest alone.[17] This exhaustion can make even simple tasks like getting dressed, preparing a meal, or taking a shower feel impossible. Patients often need to completely restructure their days, taking frequent rest periods and asking for help with activities that were once effortless.

However, research shows that gentle, regular exercise can actually help reduce fatigue and provide more energy, even though it seems counterintuitive when you’re feeling exhausted.[17] Simple activities like short, slow walks or gentle stretching exercises done while sitting or lying down can make a real difference. A hospital physiotherapist can help develop an exercise program suited to individual capabilities and limitations.[17]

Eating and maintaining weight becomes a central struggle. Many patients lose all desire to eat and may feel repulsed by foods they once enjoyed. The physical act of eating may be painful or cause nausea. Weight loss can be rapid and severe, leading to weakness and a changed physical appearance that can be distressing both to patients and their loved ones. Practical strategies include eating several small meals throughout the day instead of three large ones, choosing high-calorie foods when able to eat anything at all, staying well-hydrated even when eating is impossible, and working with a registered dietitian who specializes in cancer care.[17][19]

Sleep patterns often become disrupted. Despite feeling exhausted, many patients have trouble sleeping at night due to pain, anxiety, medication side effects, or symptoms like nausea. Establishing a regular rest schedule throughout the day, creating a comfortable sleep environment, and addressing specific symptoms that interfere with sleep can help.[17]

The emotional and psychological impact of metastatic gastric cancer is enormous. Fear, anxiety, sadness, and anger are all normal responses to this diagnosis. Many patients experience anticipatory grief—mourning the future they had imagined and the time they may not have with loved ones. Depression is common and should be treated as seriously as physical symptoms. Mental health support through counseling, support groups, or medication when appropriate is an essential part of comprehensive cancer care.

Relationships with family and friends inevitably change. Some people may not know what to say or how to act around someone with advanced cancer, leading to awkward interactions or even avoidance. At the same time, many patients find their relationships deepen as people show up to help and express their love and support. Being open about needs and feelings, when possible, helps loved ones know how to provide meaningful support.

Work life is usually significantly affected or may need to stop entirely. The physical demands of treatment, medical appointments, and symptoms often make it impossible to maintain regular work schedules. This can add financial stress to an already difficult situation, though various disability and assistance programs may be available to help.

Social activities and hobbies often need to be modified or may no longer be possible. Finding ways to stay connected to activities that bring joy, even in modified forms, helps maintain quality of life. This might mean listening to favorite music instead of attending concerts, or looking at photos from past travels rather than planning new trips.

⚠️ Important
Managing daily life with metastatic gastric cancer requires a team approach. Don’t hesitate to ask your healthcare team about available support services including nutritional counseling, pain management specialists, social workers, mental health professionals, and palliative care teams. These services exist specifically to help improve quality of life and should be accessed as early as possible, not just in the final stages of illness.

Supporting Family Members: Navigating Clinical Trials Together

Family members and loved ones play a crucial role when someone has metastatic gastric cancer, particularly when it comes to understanding treatment options including clinical trials. Families often feel helpless in the face of this disease, but there are concrete ways they can provide valuable support.

Understanding what clinical trials are and why they might be important is a good starting point. Clinical trials are research studies that test new treatments or new ways of using existing treatments. For patients with metastatic gastric cancer, where standard treatments have limited effectiveness, clinical trials may offer access to innovative therapies that aren’t yet widely available.[8] Recent years have seen significant advances in treatments for gastric cancer, particularly in immunotherapy and targeted therapies that attack specific characteristics of cancer cells.[8]

Family members can help by learning about clinical trials alongside the patient. This involves understanding that participation in a trial is completely voluntary, that patients can withdraw at any time, and that they will continue to receive the best available care regardless of whether they participate in a trial. It’s important to know that clinical trials have strict safety protocols and oversight to protect participants.

One of the most practical ways families can help is by assisting with the search for appropriate clinical trials. This can involve researching trials specifically for metastatic gastric cancer, helping to understand eligibility requirements, and organizing information about different trials to discuss with the medical team. Many cancer centers have clinical trial coordinators who can help identify suitable studies, and family members can take on the task of scheduling appointments with these coordinators and accompanying the patient to these discussions.

Families can support the decision-making process by helping to weigh the potential benefits and risks of participating in a clinical trial. This means asking important questions during medical appointments such as: What is the purpose of this trial? What treatments would be involved? What are the possible side effects? How often would appointments be required? Would participation require travel, and if so, what support is available for travel and accommodation costs?

The logistics of participating in a clinical trial can be complex, and this is another area where family support is invaluable. Trials often require frequent appointments, may involve travel to specific centers, and require careful documentation of symptoms and side effects. Family members can help with transportation, attend appointments to take notes and remember important information, help track medications and side effects, and manage the administrative aspects like paperwork and scheduling.

It’s also important for families to understand that not all patients will be eligible for every clinical trial, and that’s okay. Eligibility depends on many factors including the specific characteristics of the cancer, previous treatments received, overall health status, and other medical conditions. If a patient isn’t eligible for one trial, there may be others to consider, or standard treatments may be the most appropriate option.

Emotional support throughout the process of considering and possibly participating in clinical trials is equally important as practical support. Decision-making about experimental treatments when facing a life-threatening illness is stressful and anxiety-provoking. Family members can help by listening without judgment, respecting the patient’s ultimate decisions about their care, and continuing to provide support regardless of which treatment path is chosen.

Families should also be prepared for the possibility that a clinical trial might not work as hoped, or that the patient may experience side effects that make continuing in the trial difficult. Continuing to provide support through disappointment and helping to explore next options are important roles for family members.

Finally, families benefit from taking care of themselves as well. Supporting someone with metastatic cancer is emotionally and physically exhausting. Family members should not feel guilty about seeking their own support through counseling, support groups for caregivers, or simply taking breaks when needed. Taking care of your own health and wellbeing makes you better able to support your loved one effectively over the long term.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Trastuzumab (Herceptin and biosimilars) – A monoclonal antibody used in combination with chemotherapy for HER2-positive metastatic gastric cancer, targeting the HER2 protein that some stomach cancers produce in excess
  • Trastuzumab deruxtecan (Enhertu) – An antibody-drug conjugate used for HER2-positive metastatic stomach cancer after previous treatment with trastuzumab
  • Ramucirumab (Cyramza) – A targeted therapy that may be used with paclitaxel or alone for advanced stomach cancer when chemotherapy drugs have stopped working
  • Nivolumab (Opdivo) – An immunotherapy drug (PD-1 inhibitor) used with chemotherapy to treat advanced or metastatic gastric cancer
  • Pembrolizumab (Keytruda) – An immunotherapy drug (PD-1 inhibitor) used with chemotherapy and trastuzumab for advanced or metastatic stomach cancer
  • Zolbetuximab (Vyloy) – A monoclonal antibody used with chemotherapy for HER2-negative metastatic stomach cancer
  • Fluorouracil (5-FU) – A chemotherapy drug commonly used as part of combination regimens for metastatic gastric cancer
  • Capecitabine (Xeloda) – An oral chemotherapy drug often used in combination regimens for stage 4 or recurrent stomach cancer
  • Cisplatin – A platinum-based chemotherapy drug frequently used in combination with other agents for metastatic disease
  • Oxaliplatin – A platinum-based chemotherapy drug used in various combination regimens for advanced gastric cancer
  • Docetaxel – A chemotherapy drug in the taxane class used in treatment regimens for metastatic gastric cancer
  • Paclitaxel – A taxane chemotherapy drug often combined with other agents like ramucirumab for advanced disease
  • Epirubicin – A chemotherapy drug in the anthracycline class used in some combination regimens for metastatic gastric cancer

Ongoing Clinical Trials on Metastatic gastric cancer

  • A study to test the safety and effectiveness of ONA-255 in patients with advanced cancer including breast cancer and gastric cancer

    Recruiting

    2 1 1
    Investigated diseases:
    Spain
  • Evaluating intraperitoneal irinotecan with systemic therapy in patients with gastric peritoneal metastases

    Recruiting

    2 1 1 1
    Investigated diseases:
    The Netherlands
  • Study of Trastuzumab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

    Recruiting

    3 1 1 1
    Austria Belgium Czechia France Germany Italy +6
  • Study of HLX22, Trastuzumab, and Chemotherapy for Patients with Advanced or Metastatic Stomach and Gastroesophageal Cancer

    Recruiting

    3 1 1
    Investigated diseases:
    Germany Greece Italy Poland Portugal Romania +1
  • Study on Dostarlimab Immunotherapy for Patients with Localized Gastric Cancer with Deficient Mismatch Repair or High Microsatellite Instability

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy
  • Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated drugs:
    Belgium France Spain
  • Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

    Not recruiting

    3 1 1
    Investigated diseases:
    Belgium Czechia France Germany Italy Lithuania +5
  • Study of M9140 for Patients with Advanced Stomach Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Austria France Germany Italy Spain

References

https://www.mayoclinic.org/diseases-conditions/stomach-cancer/symptoms-causes/syc-20352438

https://www.cancerresearchuk.org/about-cancer/stomach-cancer/advanced-cancer/about-advanced-cancer

https://pmc.ncbi.nlm.nih.gov/articles/PMC5239553/

https://www.medicalnewstoday.com/articles/metastatic-stomach-cancer

https://www.mayoclinic.org/diseases-conditions/stomach-cancer/diagnosis-treatment/drc-20352443

https://www.nature.com/articles/s41598-021-02391-z

https://www.cancer.gov/types/stomach/stages

https://jhoonline.biomedcentral.com/articles/10.1186/s13045-023-01451-3

https://pmc.ncbi.nlm.nih.gov/articles/PMC3983446/

https://www.cancer.gov/types/stomach/hp/stomach-treatment-pdq

https://www.mayoclinic.org/diseases-conditions/stomach-cancer/diagnosis-treatment/drc-20352443

https://emedicine.medscape.com/article/278744-treatment

https://pmc.ncbi.nlm.nih.gov/articles/PMC6767753/

https://www.nature.com/articles/s41598-021-02391-z

https://cancer.ca/en/cancer-information/cancer-types/stomach/treatment/stage-4-and-recurrent

https://www.cancercare.org/publications/235-coping_with_stomach_cancer

https://www.cancerresearchuk.org/about-cancer/stomach-cancer/treatment/controlling-symptoms

https://www.cancercare.org/publications/224-coping_with_gastric_cancer

https://www.accc-cancer.org/acccbuzz/blog-post-template/accc-buzz/2015/02/02/8-strategies-to-help-gastric-cancer-patients-cope-with-nutrition-problems-during-treatment

https://www.mskcc.org/experience/hear-from-patients/keeping-faith-after-metastatic-stomach-cancer-christopher-s

https://pmc.ncbi.nlm.nih.gov/articles/PMC11120513/

https://www.mdanderson.org/cancerwise/-how-i-knew-i-had-stomach-cancer—six-survivors-share-their-symptoms.h00-159697545.html

FAQ

Can metastatic gastric cancer be cured?

Unfortunately, metastatic gastric cancer cannot usually be cured. Once stomach cancer has spread to distant organs, the goal of treatment shifts from cure to controlling the disease, managing symptoms, and improving quality of life for as long as possible. Treatment may help some patients live longer and feel better, but complete elimination of the cancer is rarely achieved in stage 4 disease.

How long can someone live with metastatic stomach cancer?

Survival varies greatly between individuals, but research shows the median survival is approximately 3 months overall without treatment, about 7 months with chemotherapy alone, and potentially up to 14 months with combined surgery and chemotherapy. Survival tends to be shorter (around 2 months) when cancer has spread to the liver or bones. These are averages, and individual outcomes depend on many factors including age, overall health, specific cancer characteristics, and treatment response.

What are the most common symptoms of metastatic gastric cancer?

Common symptoms include persistent indigestion or heartburn, abdominal bloating and pain, loss of appetite, unintentional weight loss, nausea and vomiting, blood in the stool or vomit, difficulty swallowing, and extreme fatigue. Symptoms can also depend on where the cancer has spread—liver metastases may cause jaundice, bone metastases may cause bone pain, and lung metastases may cause breathing difficulties or cough.

Where does metastatic gastric cancer typically spread?

The most common sites of spread are the liver (in about 48% of metastatic cases), the peritoneum or abdominal lining (32%), the lungs (15%), and bones (12%). The specific pattern of spread can vary depending on where in the stomach the cancer originated and what type of cancer cells are involved.

Should someone with metastatic gastric cancer consider clinical trials?

Clinical trials may offer access to newer treatments that aren’t yet widely available, including recent advances in immunotherapy and targeted therapies. Because standard treatments for metastatic gastric cancer have limited effectiveness, clinical trials can be a valuable option to consider. Participation is completely voluntary, and patients should discuss potential benefits and risks with their healthcare team to determine if any available trials might be appropriate for their specific situation.

🎯 Key takeaways

  • Metastatic gastric cancer means the disease has spread from the stomach to other body parts and cannot usually be cured, but treatments can help control symptoms and extend life
  • Where the cancer spreads depends on where it started in the stomach—upper stomach cancers behave completely differently than those from other areas
  • Combined treatment approaches tend to provide better outcomes than single treatments, with chemotherapy plus surgery showing longer survival than chemotherapy alone
  • Severe malnutrition and weight loss are nearly universal complications that significantly impact quality of life and ability to tolerate treatment
  • Newer targeted therapies and immunotherapies are changing the treatment landscape, particularly for patients whose tumors have specific biomarkers like HER2
  • A multidisciplinary care team including dietitians, pain specialists, mental health professionals, and palliative care providers is essential for managing this complex disease
  • Family support is crucial, particularly in helping navigate treatment decisions, managing logistics of care, and finding appropriate clinical trials
  • Despite being overwhelmed and exhausted, gentle regular exercise can actually help reduce fatigue and improve energy levels in patients with advanced cancer